Bolo N R, Hodé Y, Macher J-P
Magnetic Resonance Unit, FORENAP, Research Center for Neuroscience and Psychiatry, 27 rue du 4 RSM, Rouffach, F-68250, France.
MAGMA. 2004 May;16(6):268-76. doi: 10.1007/s10334-004-0033-0. Epub 2004 Mar 23.
Fluorine magnetic resonance spectroscopy (19F MRS), spectroscopic imaging (MRSI) and proton anatomical magnetic resonance imaging (1H MRI) were performed on brains and lower extremities of six subjects in vivo concurrently with HPLC of serum to investigate tissue and plasma drug localization and withdrawal kinetics in humans treated with fluvoxamine or fluoxetine. 19F MRS signal was unexpectedly detected in the lower extremities months after complete disappearance of signal from plasma and brain. MRSI suggested that the lower extremity fluvoxamine signal originated mainly from bone marrow. Results suggest long-term sequestration of these drugs or their metabolites mainly in bone marrow and possibly in surrounding tissue and demonstrate the usefulness of MRS to reveal drug-trapping compartments in the body.
对6名受试者的大脑和下肢进行了氟磁共振波谱(19F MRS)、波谱成像(MRSI)和质子解剖磁共振成像(1H MRI),同时对血清进行高效液相色谱分析,以研究服用氟伏沙明或氟西汀的人体组织和血浆中的药物定位及撤药动力学。在血浆和大脑中的信号完全消失数月后,在下肢意外检测到19F MRS信号。MRSI表明下肢氟伏沙明信号主要源自骨髓。结果表明这些药物或其代谢产物长期主要蓄积于骨髓,也可能蓄积于周围组织,并证明了MRS在揭示体内药物潴留部位方面的作用。